共 50 条
- [41] SGLT-2 inhibitors and their potential in the treatment of diabetes DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 453 - 467
- [43] SGLT-2 inhibitors for the prevention of recurrent nephrolithiasis BMJ-BRITISH MEDICAL JOURNAL, 2024, 387
- [45] Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors DIABETES OBESITY & METABOLISM, 2012, 14 (01): : 83 - 90
- [49] SGLT-2 inhibition and glucagon: Cause for alarm? TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2015, 26 (07): : 337 - 338
- [50] SGLT-2 inhibitors in diabetes: a focus on renoprotection REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 : S17 - S24